Trauma: Clinical Trials

5 trials for Trauma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 not yet recruiting, 1 withdrawn. 5 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 15Completed 3, Not yet recruiting 1, Withdrawn 1

Follow Trauma: new trials by email Literature Review of Trauma trials Research Report on Trauma

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Clinical Evaluation of an AI Risk Prediction System (AI-TRiPS)
AI-TRiPS Device - Trauma, Injury
Early Phase 1Not yet recruitingQueen Mary University of London12002026-06-012026-06-08
Scheduled Intranasal Ketamine
Ketamine, Placebo - Pain, Trauma
Early Phase 1WithdrawnSanford Health2023-01-012023-04-05
Neuroendocrine Risk for PTSD in Women
Estradiol patch, Placebo patch - PTSD, Trauma
Early Phase 1CompletedEmory University1272019-11-112026-07-22
PPG Project 3 - PET/MRI of the Brain-hematopoiesis-atherosclerosis Axis in PTSD Patients
fluorodeoxyglucose (FDG)-PET/MRI - PTSD, Trauma
Early Phase 1CompletedZahi Fayad1902017-11-282023-04-14
The Anti-inflammatory Effects of High-fat Nutrition; Towards a Clinical Application
nutritional intervention with Respifor and Diasip - Trauma
Early Phase 1CompletedMaastricht University Medical Center182007-03-012010-03-31

Narrower conditions

Wounds and Injuries (5)  ·  Stress Disorders, Post-Traumatic (2)  ·  Atherosclerosis (1)  ·  Pain (1)  ·  Stress Disorders, Traumatic (1)

Broader conditions

Mental Disorders (2)  ·  Trauma and Stressor Related Disorders (2)  ·  Arterial Occlusive Diseases (1)  ·  Arteriosclerosis (1)  ·  Cardiovascular Diseases (1)  ·  Neurologic Manifestations (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Signs and Symptoms (1)  ·  Stress Disorders, Traumatic (1)  ·  Vascular Diseases (1)

Interventions

Fluorodeoxyglucose F18 (1)  ·  Ketamine (1)  ·  Ortho Evra (1)

Sponsors

Emory University (1)  ·  Maastricht University Medical Center (1)  ·  Queen Mary University of London (1)  ·  Sanford Health (1)  ·  Zahi Fayad (1)

Countries

United States (2)  ·  Netherlands (1)

Top investigators

Jan-Willem Greve, professor (1)  ·  Jennifer Stevens, PhD (1)  ·  Prof. N Tai (1)  ·  Zahi Fayad, PhD (1)

NIH funding

P01HL131478 (1), R01MH117009 (1)